Radiopharm Theranostics Limited
RADX · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | -$47,949 | -$34,611 | -$30,339 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $0 | $0 | $0 |
| Other Non-Cash | -$36,645 | $24,973 | $11,409 | $20,423 |
| Operating Cash Flow | -$36,645 | -$22,976 | -$23,202 | -$9,916 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$45 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $1,771 | -$320 | -$1,485 | -$28,367 |
| Investing Cash Flow | $1,771 | -$320 | -$1,531 | -$28,370 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,900 | $2,202 | $0 | -$59 |
| Stock Issued | $53,978 | $29,646 | $10,073 | $70,000 |
| Stock Repurch. | $0 | -$1,534 | -$855 | -$4,831 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$6,646 | -$117 | $0 | $0 |
| Financing Cash Flow | $45,432 | $30,197 | $9,218 | $65,110 |
| Forex Effect | -$15 | -$25 | $235 | $127 |
| Net Chg. in Cash | $10,542 | $6,876 | -$15,280 | $26,952 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18,575 | $11,699 | $26,979 | $27 |
| End Cash | $29,117 | $18,575 | $11,699 | $26,979 |
| Free Cash Flow | -$36,645 | -$22,976 | -$24,732 | -$38,254 |